Chemical Compound
(11ss,16a)-16,17-[(1R)-Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione; Pregna-1,4-diene-3,20-dione, 16,17-[butylidenebis(oxy)]-11,21-dihydroxy-, [11ss,16a(R)]-; (11ss,16a)-16,17-[(1R)-Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione; 2H-Naphth[2',1':4,5]indeno[1,2-d][1,3]dioxole, pregna-1,4-diene-3,20-dione deriv.; (22R)-Budesonide; Dexbudesonide
CAS Registry Number
51372-29-3
Primary record
(11ss,16a)-16,17-[(1R)-Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione; Pregna-1,4-diene-3,20-dione, 16,17-[butylidenebis(oxy)]-11,21-dihydroxy-, [11ss,16a(R)]-; (11ss,16a)-16,17-[(1R)-Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione; 2H-Naphth[2',1':4,5]indeno[1,2-d][1,3]dioxole, pregna-1,4-diene-3,20-dione deriv.; (22R)-Budesonide; Dexbudesonide
- 库存
- 1,997 克
- 纯度
- 98.8 %
- CAS
- 51372-29-3
化合物标识与属性
- CAS
- 51372-29-3
- PubChem CID
- 40000
- SMILES
- CCC[C@@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C
- Canonical SMILES
- CCC[C@@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
名称与同义词
- budesonide
- Dexbudesonide
- (22R)-Budesonide
- R-Budesonide
- Pulmicort
- dexbudesonida
- Entocort
- Rhinocort
- Symbicort
- dexbudesonidum
- Budesonido
- Budesonidum
- Cortivent
- Micronyl
- Preferid
- Respules
- Spirocort
- Budeson
- Bidien
- Fvolir
- Uceris
- Dexbudesonide [INN]
- Rhinocort alpha
- Budesonide-22R
- Rhinocort Aqua
- Budecort Inhaler
- Entocort EC
- Rhinocort Allergy
- Pulmicort Respules
- (R)-Budesonide
- Pulmicort Flexhaler
- 4-one
- 51372-29-3
- UNII-2HI1006KPH
- RefChem:132381
- 2HI1006KPH
- Budesonidum [INN-Latin]
- Budesonide (22R)-Isomer
- Budesonido [INN-Spanish]
- D04QNO
- UNII-Q3OKS62Q6X
- AC1L22VC
- DEXBUDESONIDE [WHO-DD]
- SCHEMBL4095
- arachidonic acid ethanolamide
- C25H34O6
- DTXCID80202
- EINECS 257-161-7
- CCRIS 5230
- DTXSID401017799
- orb1183199
- CHEMBL2110662
- 51333-22-3
- CHEBI:181323
- BUDESONIDE (11beta,16alpha(R))
- Budesonide [USAN:BAN:INN:JAN]
- Budesonide [USAN:INN:BAN:JAN]
- CID40000
- ZINC3938751
- EINECS 257-139-7
- EBC-98092
- MFCD00083259
- MSK000561
- AKOS025311202
- BCP9000060
- C25-H34-O6
- CCG-269012
- MSK000561-100M
- NCGC00249124-01
- NCGC00249124-02
- AN-11716
- AB2000030
- J261.702A
- TL8003397
- CS-0103071
- FT-0604597
- NS00098783
- S1286
- X1051
- 4-Chlorophenyl-N-methylhydrazonopropanedinitrile
- H55574
- S 1320
- AB01274756-01
- AB01274756_02
- (22R)-Budesonide Solution in Methanol, 100ug/mL
- BRD-K90758956-001-02-9
- Q27254753
- (1S,2S,4R,6R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one
- Pregna-1,4-diene-3,20-dione,16,17-[(1R)-butylidenebis(oxy)]-11,21-dihydroxy-, (11b,16a)-
- Rhinocort;Pulmicort ;Entocort;Symbicort;Noex. Entocort EC
- 16A(R),17-(BUTYLIDENEBIS(OXY))-11B,21-DIHYDROXYPREGNA-1,4-DIENE-3,20-DIONE
- (1~{s},2~{s},4~{r},6~{r},8~{s},9~{s},11~{s},12~{s},13~{r})-9,13-Dimethyl-11-Oxidanyl-8-(2-Oxidanylethanoyl)-6-Propyl-5,7-Dioxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosa-14,17-Dien-16-One
- (R)-11.BETA.,16.ALPHA.,17,21-TETRAHYDROXYPREGNA-1,4-DIENE-3,20-DIONE 16,17-ACETAL WITH BUTYRALDEHYDE
- (R)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione 16,17-acetal with butyraldehyde
- PREGNA-1,4-DIENE-3,20-DIONE, 16,17-BUTYLIDENEBIS(OXY)-11,21-DIHYDROXY-, (11.BETA.16.ALPHA.(R))
- 16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione
- 16alpha(R),17-(Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
- 16alpha(R),17-[butylidenebis(oxy)]-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
- 16alpha,17-[(R)-Butylidenebisoxy]-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
- (11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
- (11-beta,16-alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
- (11ss,16a)-16,17-[(1R)-Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione; Pregna-1,4-diene-3,20-dione, 16,17-[butylidenebis(oxy)]-11,21-dihydroxy-, [11ss,16a(R)]-; (11ss,16a)-16,17-[(1R)-Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione; 2H-Naphth[2',1':4,5]indeno[1,2-d][1,3]dioxole, pregna-1,4-diene-3,20-dione deriv.; (22R)-Budesonide; Dexbudesonide
- (1S,2S,4R,6R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosa-14,17-dien-16-one
- (4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-Hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H,8H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
- (4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
- (4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
- (6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-
- (6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-one
- (R,S)-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
- (RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
- 257-161-7
- 8W5
- Pregna-1,4-diene-3,20-dione, 16,17-[butylidenebis(oxy)]-11,21-dihydroxy-, (11.beta.,16.alpha.)-
- Pregna-1,4-diene-3,20-dione, 16,17-[butylidenebis(oxy)]-11,21-dihydroxy-, [11.beta.,16.alpha.(R)]-
- PREGNA-1,4-DIENE-3,20-DIONE, 16,17-BUTYLIDENEBIS(OXY)-11,21-DIHYDROXY-, (11BETA16ALPHA(R))